(Q79794476)
Statements
A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer (English)
Allison W Kurian
Rebecca Newton Thompson
Allison F Gaw
Sally Arai
Rafael Ortiz
1 February 2007